Nonalcoholic Steatohepatitis
📧 Sign up to get email alerts when something new happens for Nonalcoholic Steatohepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: De Novo Lipogenesis in Severity of NAFLD
A completed clinical trial from the University of Missouri-Columbia investigates the role of de novo lipogenesis in the severity of nonalcoh…
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR) [Phase 3]
Phase 3 trial ARMOR evaluating Aramchol for nonalcoholic steatohepatitis is currently suspended; results were posted on 2024-12-16.
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224 [Phase 2]
Phase 2 trial evaluating multiple doses of ION224 for safety, efficacy, and pharmacokinetics in nonalcoholic steatohepatitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As Reference
This completed clinical trial compared magnetic resonance elastography (MRE) and corrected-T1 (cT1) for diagnosing fibrosis and inflammation…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: A Study of FT 4101 in Overweight/Obese Participants With Non-alcoholic Steatohepatitis [Phase 1, Phase 2]
The FT-4101 trial in overweight or obese participants with nonalcoholic steatohepatitis (NASH) was terminated, and results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH [Phase 2]
A Phase 2 study evaluating the efficacy and safety of DA-1241 in nonalcoholic steatohepatitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis [Phase 2]
A Phase 2 trial update reports results for saroglitazar magnesium in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Resu…
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Dose Escalation Study of Kylo-0603 in Healthy Subjects [Phase 1]
A Phase 1 dose-escalation trial of Kylo-0603 in healthy subjects has completed, examining initial safety and pharmacokinetics for a potentia…
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: FTIH Study of ECC0509 in Healthy Volunteers [Phase 1]
Phase 1 trial of ECC0509 in healthy volunteers has completed; the study investigated safety and pharmacology, with nonalcoholic steatohepati…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: PK of NRL972 in Patients with Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD) [Phase 2]
Phase 2 study assessing the pharmacokinetics of NRL972 in patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis ha…
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment [Phase 3]
A Phase 3 global trial evaluating obeticholic acid for nonalcoholic steatohepatitis with fibrosis was terminated, and results have been post…
-
CLINICAL_TRIALS trial_result · 2024-09-04Clinical Trial Update: Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH) [Phase 2]
A Phase 2 trial evaluating the safety and effectiveness of BMS-986263 in adults with compensated cirrhosis due to nonalcoholic steatohepatit…
-
CLINICAL_TRIALS trial_result · 2024-08-19Clinical Trial Update: A Sub Study of the Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)
This is a completed sub-study of Miricorilant in patients with presumed nonalcoholic steatohepatitis (NASH). The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 trial evaluating the safety and efficacy of an oral insulin formulation in adults with type 2 diabetes and nonalcoholic steatohepati…
-
CLINICAL_TRIALS trial_result · 2024-07-17Clinical Trial Update: A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 Trial [Phase 2]
Phase 2 safety and tolerability update for LPCN 1144 in subjects who completed the LPCN 1144-18-002 trial for Nonalcoholic Steatohepatitis.
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: Prevalence of Steatosis and Steatohepatitis in Patients Undergoing Bariatric Surgery; a Biopsy-based Study
A completed biopsy-based study evaluates how common liver steatosis and nonalcoholic steatohepatitis are among patients undergoing bariatric…
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: A Clinical Trial of BGT-002 Tablets in Subjects With Nonalcoholic Steatohepatitis [Phase 1, Phase 2]
A Phase 1/2 trial evaluating BGT-002 tablets for nonalcoholic steatohepatitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-21Clinical Trial Update: Pentoxifylline in Treatment of Patients With Nonalcoholic Steatohepatitis [Phase 3]
Phase 3 clinical trial evaluating pentoxifylline for nonalcoholic steatohepatitis has completed, according to the trial registry update.
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH [Phase 2]
The document reports the completion of a Phase 2 trial evaluating the efficacy and safety of VK2809 in adults with biopsy-confirmed nonalcoh…
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: AVIATION Study: A Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TERN-201 in Patients With Non-Cirrhotic Non-Alcoholic Steatohepatitis [Phase 1]
Phase 1 AVIATION trial evaluating safety, pharmacokinetics/pharmacodynamics and preliminary efficacy of TERN-201 in noncirrhotic nonalcoholi…
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: A Phase II Clinical Trial of Chiglitazar for NASH [Phase 2]
A Phase II trial of chiglitazar for nonalcoholic steatohepatitis has completed. The study was sponsored by Chipscreen Biosciences, Ltd.
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease [Phase 1, Phase 2]
Aspirin is being studied for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Phase 1/2. The trial is completed, and res…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH) [Phase 1]
This clinical trial update reports termination of a Phase 1 study of ALN-HSD in healthy adult subjects and adults with nonalcoholic steatohe…
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: A Study of MK-3655 in Individuals With Pre-cirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-3655-001) [Phase 2]
A Phase 2 study of MK-3655 for pre-cirrhotic Nonalcoholic Steatohepatitis was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH [Phase 1, Phase 2]
A multiple ascending dose study of pegozafermin in participants with biopsy-confirmed NASH or NAFLD at high risk of NASH has completed phase…